Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study is to investigate the safety and efficacy of PXS-4728A as an intervention therapy in participants with iRBD. This study will be conducted in participants aged 50 to 80 years of age and will investigate a single dose level.
Epistemonikos ID: 23c13b96469d3a05c4b97641917d13596c54f804
First added on: Feb 19, 2024